Acidosis: Diagnosis and Treatment

Chapter
First Online:

Abstract

Acidosis is characterized by a decrease in plasma pH. The first chapter will focus on the pathophysiological principles responsible for the development of an acidosis. Clinical signs of an acidosis are not specific, and the diagnosis is based on the context, on the history, and finally on the biological abnormalities. Metabolic acidosis (MA) must be distinguished from respiratory acidosis (RA) because causes and treatment are totally different. The treatment of acidosis will be developed in the last chapter.

This is a preview of subscription content, log in to check access.

References

  1. 1.
    Berend K, de Vries APJ, Gans ROB (2014) Physiological approach to assessment of acid-base disturbances. New Engl J Med 371:1434–1445CrossRefPubMedGoogle Scholar
  2. 2.
    Madger S (1998) Pathophysiology of metabolic acid-base disturbances in patients with critical illness. In: Ronco C, Bellomo R (eds) Critical care nephrology. Kluwer Academic Publisher, Dordrecht, pp 279–296Google Scholar
  3. 3.
    Kraut JA, Madias NE (2010) Metabolic acidosis: pathophysiology, diagnosis and management. Nat Rev Nephrol 6:274–278CrossRefPubMedGoogle Scholar
  4. 4.
    Fencl V, Jabor A, Kazda A, Figge J (2000) Diagnosis of metabolic acid-base disturbances in critically ill patients. Am J Resp Crit Care Med 162:2246–2251CrossRefPubMedGoogle Scholar
  5. 5.
    Kaplan LJ, Frangos S (2005) Clinical review: acid-base abnormalities in the intensive care unit. Crit Care 9:198–203CrossRefPubMedGoogle Scholar
  6. 6.
    Stewart PA (1978) Independent and dependent variables of acid-base control. Resp Physiol 33:9–26CrossRefGoogle Scholar
  7. 7.
    Kellum J, Elbers PWG (2009) Stewart’s textbook of acid-base. Lulu Enterprises, Amsterdam, Netherlands, 501 pGoogle Scholar
  8. 8.
    Quintard H, Hubert S, Ichai C (2007) Qu’apporte le modèle de Stewart à l’interprétation des troubles de l’équilibre acide base? Ann Fr Anesth Réanim 26:423–433CrossRefPubMedGoogle Scholar
  9. 9.
    Gattinoni L, Lissoni A (1998) Pathophysiology and diagnosis of respiratory acid-base disturbances in patients with critical illness. In: Ronco C, Bellomo R (eds) Critical care nephrology. Kluwer Academic Publisher, Dordrecht, pp 297–326CrossRefGoogle Scholar
  10. 10.
    Figge J, Jabor A, Kazda A, Fencl V (1998) Anion gap and hypoalbuminemia. Crit Care Med 26:1807–1810CrossRefPubMedGoogle Scholar
  11. 11.
    Kraut JA, Madias NE (2007) Serum anion gap: its uses and limitations in clinical medicine. Clin J Am Soc Nephrol 2:162–174CrossRefPubMedGoogle Scholar
  12. 12.
    Dinh CH, Grandinetti A, Joffe A et al (2006) Correcting the anion gap for hypoalbuminemia does not improve detection of hyperlactatemia. Emerg Med J 23:627–632CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Kellum JA, Kramer DJ, Pinsky MR (1995) Strong ion gap: a methodology for exploring unexplained anions. J Crit Care 10:51–55CrossRefPubMedGoogle Scholar
  14. 14.
    Szrama J, Smuszkiewicz P (2016) An acid-base disorders analysis with the use of the Stewart approach in patients with sepsis treated in an intensive care unit. Anaesth Intensive Ther 48:181–184Google Scholar
  15. 15.
    Doberer D, Funk GC, Kirchner K, Schneeweiss B (2009) A critique of Stewart’s approach: the chemical mechanism of dilutional acidosis. Intensive Care Med 35:2173–2180CrossRefPubMedGoogle Scholar
  16. 16.
    Dubin A, Menises MM, Masevicius FD et al (2007) Comparison of three different methods of evaluation of metabolic acid base disorders. Crit Care Med 35:1264–1270CrossRefPubMedGoogle Scholar
  17. 17.
    Orban JC, Leverve X, Ichai C (2010) Lactate: le substrat énergétique de demain. Réanimation 19:384–392CrossRefGoogle Scholar
  18. 18.
    Levraut J, Bounatirou T, Ichai C, Ciais JF, Jambou P, Grimaud D (1997) Reliability of anion gap as an indicator of blood lactate level in critically ill patients. Intensive Care Med 23:417–422CrossRefPubMedGoogle Scholar
  19. 19.
    Kraut JA, Kurtz I (2005) Metabolic acidosis of CKD: diagnosis, clinical characteristics, and treatment. Am J Kidney Dis 45:978–993CrossRefPubMedGoogle Scholar
  20. 20.
    Gucyetmez B, Atalan HK (2016) Non-lactate strong ion difference: a clearer picture. J Anesth 30:391–396CrossRefPubMedGoogle Scholar
  21. 21.
    Orban JC, Lena D, Bonciu M, Grimaud D, Ichai C (2007) Complications métaboliques aiguës du diabète. Urgence pratique 83:13–17Google Scholar
  22. 22.
    Misra S, Oliver NS (2015) Utility of ketone measurement in the prevention, diagnosis and management of diabetic ketoacidosis. Diabet Med 32:14–23CrossRefPubMedGoogle Scholar
  23. 23.
    Forni LG, McKinnon W, Hilton PJ (2006) Unmeasured anions in metabolic acidosis: unravelling the mystery. Crit Care 10:220–224CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Rocktäschel J, Morimatsu H, Uchino S et al (2003) Acid-base status of critically ill patients with acute renal failure: analysis based on Stewart-Figge methodology. Crit Care 7:R60–R66CrossRefGoogle Scholar
  25. 25.
    Story DA, Morimatsu H, Bellomo R (2006) Hyperchloremic acidosis in the critically ill: one of the strong-ion acidoses? Anesth Analg 103:144–148CrossRefPubMedGoogle Scholar
  26. 26.
    Karet FE (2009) Mechanisms in hyperkalemic renal tubular acidosis. J Am Soc Nephrol 20:251–254CrossRefPubMedGoogle Scholar
  27. 27.
    Laing CM, Unwin RJ (2006) Renal tubular acidosis. J Nephrol 19(suppl 9):S46–S52PubMedGoogle Scholar
  28. 28.
    Reddy S, Weinberg L, Young P (2016) Crystalloid fluid therapy. Crit Care 20:59CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Scheingraber S, Rehm M, Sehmisch C, Finsterer U (1999) Rapid saline infusion produces hyperchloremic acidosis in patients undergoing gynecologic surgery. Anesthesiology 90:1265–1270CrossRefPubMedGoogle Scholar
  30. 30.
    Kellum JA, Bellomo R, Kramer DJ, Pinsky MR (1998) Etiology of metabolic acidosis during saline resuscitation in endotoxemia. Shock 9:364–368CrossRefPubMedGoogle Scholar
  31. 31.
    Ichai C, Levraut J (2003) Hyperchloremic metabolic acidosis and fluid resuscitation. Crit Care & Shock 6:31–39Google Scholar
  32. 32.
    Langer T, Santini A, Scotti E, Van Regenmortel N, Malbrain MLNG, Caironi P (2015) Intravenous balanced solutions: from physiology to clinical evidence. Anaesth Intensive Ther 47:s77–s88CrossRefGoogle Scholar
  33. 33.
    Morgan TJ (2014) The ideal crystalloid—What is “balanced”? Curr Opin Crit Care 19:299–307CrossRefGoogle Scholar
  34. 34.
    McDermid RC, Raghunathan K, Romanovsky A, Shaw AD, Bagshaw SM (2014) Controversies in fluid therapy: type, dose and toxicity. World J Crit Care Med 3:24–33CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Waters JH, Gottlieb A, Schoenwald P, Popovich MJ, Sprung J, Nelson DR (2001) Normal saline versus lactated ringer’s solution for intraoperative fluid management in patients undergoing abdominal aortic aneurysm repair: an outcome study. Anesth Analg 93:817–822CrossRefPubMedGoogle Scholar
  36. 36.
    Liskaser FJ, Bellomo R, Hayhoe M et al (2000) Role of pump prime in the etiology and pathogenesis of cardiopulmonary bypass-associated acidosis. Anesthesiology 93:1170–1173CrossRefPubMedGoogle Scholar
  37. 37.
    Bellomo R, Morimatsu H, French C et al (2006) The effects of saline or albumin resuscitation on acid-base status and serum electrolytes. Crit Care Med 34:2891–2897CrossRefPubMedGoogle Scholar
  38. 38.
    Moon PF, Kramer GC (1995) Hypertonic saline-dextran resuscitation for hemorrhagic shock induces transient mixed acidosis. Crit Care Med 23:323–331CrossRefPubMedGoogle Scholar
  39. 39.
    Kellum JA (2002) Fluid resuscitation and hyperchloremic acidosis in experimental sepsis: improved short-term survival and acid-base balance with Hextend compared with saline. Crit Care Med 30:300–305CrossRefPubMedGoogle Scholar
  40. 40.
    Lobo DN, Awad S (2014) Should chloride-rich crystalloids remain the mainstay of fluid resuscitation to prevent “pre-renal” acute kidney injury?: con. Kidney Int 86:1096–1105CrossRefPubMedPubMedCentralGoogle Scholar
  41. 41.
    Wilcox CS (1983) Regulation of renal blood flow by plasma chloride. J Clin Invest 71:726–735CrossRefPubMedPubMedCentralGoogle Scholar
  42. 42.
    Chowdhury AH, Cox EF, Francis ST, Lobo DN (2012) A randomized, controlled, double-blind cross over study on the effects of 2-L infusions of NaCl 0.9% saline and Plasma-Lyte® 48 on renal blood flow velocity and renal cortical tissue perfusion in healthy volunteers. Ann Surg 256:18–24CrossRefPubMedGoogle Scholar
  43. 43.
    Young P, Bailey M, Beasley R et al (2015) Effect of buffered crystalloid solution vs saline on acute kidney injury among patients in the intensive care unit. The SPLIT randomized clinical trial. JAMA 314:1701–1710CrossRefPubMedGoogle Scholar
  44. 44.
    Wilkes NJ, Wool R, Mutch M et al (2001) The effects of balanced versus saline-based hetastarch and crystalloid solutions on acid-base and electrolyte status and gastric mucosal perfusion in elderly surgical patients. Anesth Analg 93:811–816CrossRefPubMedGoogle Scholar
  45. 45.
    O’Malley CM, Frumento RJ, Hardy MA et al (2005) A randomized, double-blind comparison of lactated Ringer’s solution and 0.9% NaCl during renal transplantation. Anesth Analg 100:1518–1524CrossRefPubMedGoogle Scholar
  46. 46.
    Martin G, Bennett-Guerrero E, Wakeling H et al (2002) A prospective, randomized comparison of thromboelastography coagulation profile in patients receiving lactated Ringer’s solution, 6% hetastarch in a balanced-saline vehicle, or 6% hetastarch in saline during major surgery. J Cardiothorac Vasc Anesth 16:441–446CrossRefPubMedGoogle Scholar
  47. 47.
    Moretti EW, Robertson KM, El-Moalem H, Gan TJ (2003) Intraoperative colloid administration reduces postoperative outcomes compared with crystalloid administration. Anesth Analg 96:611–617PubMedGoogle Scholar
  48. 48.
    Reddy S, Bailey M, Beasley R et al (2016) Effect of saline 0.9% or Plasma-Lyte 148 therapy on feeding intolerance in patients receiving nasogastric enteral nutrition. Crit Care Resusc 18:198–204PubMedGoogle Scholar
  49. 49.
    Kellum JA, Song M, Venkataraman R (2004) Effects of hyperchloremic acidosis on arterial pressure and circulating inflammatory molecules in experimental sepsis. Chest 125:243–248CrossRefPubMedGoogle Scholar
  50. 50.
    Kellum JA, Song M, Li J (2004) Lactic, and hydrochloric acids induce different patterns of inflammatory response in LPS-stimulated RAW 264.7 cells. Am J Physiol Regul Integr Comp Physiol 286:R686–R692CrossRefPubMedGoogle Scholar
  51. 51.
    Raghunathan K, Shaw A, Nathanson B et al (2014) Association between the choice of IV crystalloid and in-hospital mortality among critically ill adults with sepsis. Crit Care Med 42:1585–1591CrossRefPubMedGoogle Scholar
  52. 52.
    Krajewski ML, Raghunathan K, Paluszkiewicz SM, Schermer CR, Shaw AD (2015) Meta-analysis of high- versus low-chloride content in perioperative and critical care fluid resuscitation. Br J Surg 102:24–36CrossRefPubMedGoogle Scholar
  53. 53.
    Cooper DJ, Walley KR, Wiggs BR, Russel JA (1990) Bicarbonate does not improve hemodynamics in critically ill patients who have lactic acidosis: a prospective, controlled clinical study. Ann Intern Med 112:492–498CrossRefPubMedGoogle Scholar
  54. 54.
    Gehlbach BK, Schmidt GA (2004) Bench-to-bedside review: treating acid-base abnormalities in the intensive care unit—the role of buffers. Crit Care 8:259–265CrossRefPubMedPubMedCentralGoogle Scholar
  55. 55.
    Duburcq T, Favory R, Matthieu D et al (2014) Hypertonic sodium lactate improves fluid balance and hemodynamics in porcine endotoxic shock. Crit Care 18:467CrossRefPubMedPubMedCentralGoogle Scholar
  56. 56.
    Fang ZX, Li YF, Zhou XQ et al (2008) Effects of resuscitation with crystalloid fluids on cardiac function in patients with severe sepsis. BMC Infect Dis 8:50CrossRefPubMedPubMedCentralGoogle Scholar
  57. 57.
    Rocktäschel J, Morimatsu H, Uchino S, Ronco C, Bellomo R (2003) Impact of continuous veno-venous hemofiltration on acid-base balance. Int J Artif Organs 26:19–25PubMedGoogle Scholar
  58. 58.
    Naka T, Bellomo R (2004) Bench-to-bedside review: treating acid-base abnormalities in the intensive care unit—the role of renal replacement therapy. Crit Care 8:108–114CrossRefPubMedPubMedCentralGoogle Scholar
  59. 59.
    Gunnerson KJ, Saul M, He S, Kellum JA (2006) Lactate versus non-lactate metabolic acidosis: a retrospective outcome evaluation of critically ill patients. Crit Care 10:R22CrossRefPubMedPubMedCentralGoogle Scholar
  60. 60.
    Allyn J, Vaudroux D, Jabot J et al (2016) Prognosis of patients presenting extreme acidosis (pH <7) on admission to intensive care unit. J Crit Care 31:243–248CrossRefPubMedGoogle Scholar
  61. 61.
    Orchard C, Cingolani H (1994) Acidosis and arrhythmias in cardiac muscle. Cardiovasc Res 28:1312–1319CrossRefPubMedGoogle Scholar
  62. 62.
    Barton M, Lake CR, Rainey TG, Chernow B (1982) Is catecholamine release pH mediated? Crit Care Med 10:751–753CrossRefPubMedGoogle Scholar
  63. 63.
    Huang YG, Wong KC, Yip WH, McJames SW, Pace N (1995) Cardiovascular response to graded doses of three catecholamines during lactic and hydrochloric acidosis in dogs. Br J Anaesth 74:583–590CrossRefPubMedGoogle Scholar
  64. 64.
    Martini WZ (2009) Coagulopathy by hypothermia and acidosis: mechanisms of thrombin generation and fibrinogen availability. J Trauma 67:202–208CrossRefPubMedGoogle Scholar
  65. 65.
    Jaber S, Jung B, Sebbane M et al (2008) Alteration of the piglet diaphragm contractility in vivo and its recovery after acute hypercapnia. Anesthesiology 108:651–658CrossRefPubMedPubMedCentralGoogle Scholar
  66. 66.
    Caples SM, Rasmussen DL, Lee WY, Wolfert MZ, Hubmayr RD (2009) Impact of buffering hypercapnic acidosis on cell wounding in ventilator-injured rat lungs. Am J Physiol Lung Cell Mol Physiol 296:L140–L144CrossRefPubMedGoogle Scholar
  67. 67.
    Luo H, Chang Y, Cai H, Wang D, Guo Q (2008) The effect of hypercapnic acidosis preconditioning on rabbit myocardium. J Huazhong Univ Sci Technolog Med Sci 28:706–710CrossRefPubMedGoogle Scholar
  68. 68.
    López D, Rodríguez-Sinovas A, Agulló L, Inserte J, Cabestrero A, García-Dorado D (2008) Acidic reoxygenation protects against endothelial dysfunction in rat aortic rings submitted to simulated ischemia. Am J Physiol Heart Circ Physiol 295:H2409–H2401CrossRefPubMedGoogle Scholar
  69. 69.
    Flacke JP, Kumar S, Kostin S, Reusch HP, Ladilov Y (2009) Acidic preconditioning protects endothelial cells against apoptosis through p38- and Akt-dependent Bcl-xL overexpression. Apoptosis 14:90–96CrossRefPubMedGoogle Scholar
  70. 70.
    Cohen MV, Yang XM, Downey JM (2007) The pH hypothesis of postconditioning: staccato reintroduces oxygen and perpetuates myocardial acidosis. Circulation 115:1895–1903CrossRefPubMedGoogle Scholar
  71. 71.
    Inserte J, Barba I, Hernando V et al (2008) Effect of acidic reperfusion on prolongation of intracellular acidosis and myocardial salvage. Cardiovasc Res 77:782–790CrossRefPubMedGoogle Scholar
  72. 72.
    Thatte HS, Rhee JH, Zagarins SE et al (2004) Acidosis-induced apoptosis in human and porcine heart. Ann Thorac Surg 77:1376–1383CrossRefPubMedGoogle Scholar
  73. 73.
    Viallon A, Zeni F, Lafond P et al (1999) Does bicarbonate therapy improve the management of severe diabetic ketoacidosis? Crit Care Med 27:2690–2693CrossRefPubMedGoogle Scholar
  74. 74.
    Vukmir RB (2006) Sodium bicarbonate improves outcome in prolonged prehospital cardiac arrest. Am J Emerg 24:156–161CrossRefGoogle Scholar
  75. 75.
    Castaing Y, Bengler C, Delafosse B et al (1998) Correction de l’acidose métabolique en réanimation. XIXè Conférence de Consensus en Réanimation et Médecine. Réanim Urg 8:426–432Google Scholar
  76. 76.
    Leverve XM, Boon C, Hakim T, Anwar M, Siregar E, Mustafa I (2008) Half-molar sodium-lactate has a beneficial effect in patients after coronary artery bypass grafting. Intensive Care Med 34:1796–1803CrossRefPubMedGoogle Scholar
  77. 77.
    Kotchen TA (2005) Contributions of sodium and chloride to NaCl-induced hypertension. Hypertension 45:849–850CrossRefPubMedGoogle Scholar
  78. 78.
    Verkman AS, Galietta LJV (2009) Chloride channels as drugs targets. Nature 8:153–171Google Scholar
  79. 79.
    Beck J, Lenart B, Kintner DB, Sun D (2003) Na-K-Cl cotransporter contributes to glutamate-mediated excitotoxicity. J Neurosci 23:5061–5068PubMedGoogle Scholar
  80. 80.
    Pond BB, Galeffi F, Ahrens R, Schwartz-Bloom RD (2004) Chloride transport inhibitors influence recovery from oxygen-glucose deprivation-induced cellular injury in adult hippocampus. Neuropharmacology 47:253–262CrossRefPubMedGoogle Scholar
  81. 81.
    Sardini A (2007) Cell volume homeostasis: the role of volume-sensitive chloride channels. Adv Mol Cell Biol 38:199–214CrossRefGoogle Scholar
  82. 82.
    Kahle KT, Staley KJ, Nahed BV et al (2008) Roles of the cation-chloride cotransporters in neurological disease. Nature Clin Pract 4:490–503CrossRefGoogle Scholar
  83. 83.
    O’Donnell ME, Duong V, Suvatne J, Foroutan S, Johnson DM (2005) Arginine vasopressin stimulation of cerebral microvascular endothelial cell Na-K-Cl cotransporter activity is V1 receptor and [Ca] dependent. Am J Physiol Cell Physiol 289:C283–C292CrossRefPubMedGoogle Scholar
  84. 84.
    Chen H, Luo J, Kintner DB, Shull GE, Sun D (2005) Na+-dependent chloride transporter (NKCC1) -null mice exhibit less gray and whiter matter damage after focal cerebral ischemia. J Cereb Blood Flow Metab 25:54–66CrossRefPubMedGoogle Scholar
  85. 85.
    Inoue H, Okada Y (2007) Roles of volume-sensitive chloride channel in excitotoxic neuronal injury. J Neurosci 27:1445–1455CrossRefPubMedGoogle Scholar
  86. 86.
    Su G, Kintner DB, Flagella M, Shull GE, Sun D (2002) Astrocytes from Na+-K+-Cl− cotransporter-null mice exhibit absence of swelling and decrease in EEA release. Am J Physiol Cell Physiol 282:C1147–C1160CrossRefPubMedGoogle Scholar
  87. 87.
    Levraut J, Giunti C, Ciebiera JP et al (2001) Initial effect of sodium bicarbonate on intracellular pH depends on the extracellular nonbicarbonate buffering capacity. Crit Care Med 29:1033–1039CrossRefPubMedGoogle Scholar
  88. 88.
    Boyd JH, Walley KR (2008) Is there a role for sodium bicarbonate in treating lactic acidosis from shock? Curr Opin Crit Care 14:379–383CrossRefPubMedGoogle Scholar
  89. 89.
    El-Solh AA, Abou Jaoude P, Porhomayon J (2010) Bicarbonate therapy in the treatment of septic shock: a second look. Intern Emerg Med 5:341–347CrossRefPubMedGoogle Scholar
  90. 90.
    Dellinger RP, Lévy MM, Carlet JM et al (2008) Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med 34:17–60CrossRefPubMedGoogle Scholar
  91. 91.
    Morrison LJ, Deakin CD, Morley PT et al (2010) Advanced life support chapter collaborators. Part 8: advanced life support: 2010 International consensus on cardiopulmonary resuscitation and emergency cardiovascular care science with treatment recommendations. Circulation 122:213–247Google Scholar
  92. 92.
    Ritter JM, Doktor HS, Benjamin N (1990) Paradoxical effect of bicarbonate on cytoplasmic pH. Lancet 10:1243–1246CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG 2018

Authors and Affiliations

  1. 1.Intensive Care UnitHôpital Pasteur 2NiceFrance
  2. 2.IRCAN (INSERM U1081, CNRS UMR 7284), University Hospital of NiceNiceFrance

Personalised recommendations